These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 38674011)

  • 1. Inflammatory Response and Defects on Myelin Integrity in the Olfactory System of K18hACE2 Mice Infected with SARS-CoV-2.
    Martin-Lopez E; Brennan B; Mao T; Spence N; Meller SJ; Han K; Yahiaoui N; Wang C; Iwasaki A; Greer CA
    eNeuro; 2024 Jun; 11(6):. PubMed ID: 38834299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidences of neurological injury caused by COVID-19 from glioma tissues and glioma organoids.
    Hu H; Wang C; Tao R; Liu B; Peng D; Chen Y; Zhang W
    CNS Neurosci Ther; 2024 Jun; 30(6):e14822. PubMed ID: 38923860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
    Peluso MJ; Ryder D; Flavell RR; Wang Y; Levi J; LaFranchi BH; Deveau TM; Buck AM; Munter SE; Asare KA; Aslam M; Koch W; Szabo G; Hoh R; Deswal M; Rodriguez AE; Buitrago M; Tai V; Shrestha U; Lu S; Goldberg SA; Dalhuisen T; Vasquez JJ; Durstenfeld MS; Hsue PY; Kelly JD; Kumar N; Martin JN; Gambhir A; Somsouk M; Seo Y; Deeks SG; Laszik ZG; VanBrocklin HF; Henrich TJ
    Sci Transl Med; 2024 Jul; 16(754):eadk3295. PubMed ID: 38959327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection.
    Ziegler CGK; Owings AH; Galeas-Pena M; Kazer SW; Miao VN; Navia AW; Tang Y; Bromley JD; Lotfy P; Sloan M; Laird H; Williams HB; George M; Drake RS; Pride Y; Abraham GE; Senitko M; Robinson TO; Diamond G; Lionakis MS; Shalek AK; Ordovas-Montanes J; Horwitz BH; Glover SC
    Microbiol Spectr; 2024 Jun; 12(6):e0351623. PubMed ID: 38687064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral lesions with immunohistochemical evidence of Sars-CoV-2 in swab-negative post-COVID syndrome.
    Limongelli L; Favia G; Maiorano E; D'Amati A; Pispero A; Ingravallo G; Barile G; Tempesta A; Dell'Olio F; Siciliani RA; Capodiferro S
    Oral Dis; 2024 Apr; 30(3):1264-1272. PubMed ID: 36775262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kids' noses resist COVID-19.
    Zanoni I
    J Exp Med; 2024 Sep; 221(9):. PubMed ID: 38949639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New evidence suggests SARS-CoV-2 neuroinvasion along the nervus terminalis rather than the olfactory pathway.
    von Bartheld CS; Butowt R
    Acta Neuropathol; 2024 Jan; 147(1):10. PubMed ID: 38183496
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Liang F; Wang Y
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory immunology: the missing piece in airway and CNS defence.
    Wellford SA; Moseman EA
    Nat Rev Immunol; 2024 Jun; 24(6):381-398. PubMed ID: 38097777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histochemical Evidence for Reduced Immune Response in Nasal Mucosa of Patients with COVID-19.
    Power Guerra N; Bierkämper M; Pablik J; Hummel T; Witt M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3
    Abdolmohammadi-Vahid S; Baradaran B; Sadeghi A; Bezemer GFG; Kiaee F; Adcock IM; Folkerts G; Garssen J; Mortaz E
    Exp Mol Pathol; 2024 Jun; 137():104897. PubMed ID: 38691979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.